Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Universitaire Ziekenhuizen KU Leuven
With
KU Leuven
* Prospective, interventional, randomized, double-blind, placebo-controlled trial.
* Clinical setting (tertiary University Hospital).
* Investigator-driven, no pharmaceutical sponsor.
* Lung transplant recipients.
* Add-on of study-drug (placebo or montelukast) to 'standard of care'
* 1:1 inclusion ratio (placebo:montelukast).
* Randomisation at diagnosis of chronic rejection after informed consent.
Age
18–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Diagnosis of fBOS
Signed informed consent
Age at least 18 years old at moment of transplantation